HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study

Authors:

Abstract
No abstract available
Funding Information
  • Prostate Cancer Foundation
  • National Institutes of Health
  • US Department of Defense
  • Howard Hughes Medical Institute
  • American Cancer Society
  • Conquer Cancer Foundation
  • American Society of Clinical Oncology
  • Cleveland Clinic Research Programs Committee
  • Department of Radiation Oncology
  • Gail and Joseph Gassner Development Funds
  • Department of Radiation Oncology
  • US Department of Defense
  • Conquer Cancer Foundation
  • American Society of Clinical Oncology
  • Prostate Specialized Program of Research Excellence (P50-CA091956)
  • Gail and Joseph Gassner Development Funds
  • Howard Hughes Medical Institute
  • Prostate Cancer Foundation
  • American Cancer Society
  • US Army Medical Research and Materiel Command (W81XWH-09–1-0301)
  • National Institutes of Health (R01CA172382, R01CA190289, R01CA168899)

This publication has 41 references indexed in Scilit: